Publication:

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease (2012)

Author(s): Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Hughes A, Jacoby R, Jones R, Jones R, McKeith I, Macharouthu A, O'Brien J, Passmore P, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown R, Banerjee S, Onions C, Griffin M, Adams J, Gray R, Johnson T, Bentham P, Phillips P

      • Date: 01-03-2012
      • Journal: New England Journal of Medicine
      • Volume: 366
      • Issue: 10
      • Pages: 893-903
      • Publisher: Massachusetts Medical Society
      • Publication type: Article
      • Bibliographic status: Published

      Keywords: PLACEBO-CONTROLLED TRIAL QUALITY-OF-LIFE DOUBLE-BLIND CHOLINESTERASE-INHIBITORS RECEIVING DONEPEZIL CLINICAL-TRIALS DEMENTIA POPULATION EFFICACY 24-WEEK